Publicaciones en las que colabora con Tomas Sobrino Moreiras (18)

2020

  1. Iron Deposits in Periaqueductal Gray Matter Are Associated with Poor Response to OnabotulinumtoxinA in Chronic Migraine

    Toxins, Vol. 12, Núm. 8

2019

  1. Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine

    Neurology, Vol. 92, Núm. 10, pp. E1076-E1085

2015

  1. Study of Protein Expresion in Peri-Infarct Tissue after Cerebral Ischemia

    Scientific Reports, Vol. 5

2014

  1. Human recombinant glutamate oxaloacetate transaminase 1 (GOT1) supplemented with oxaloacetate induces a protective effect after cerebral ischemia

    Cell Death and Disease, Vol. 5, Núm. 1

  2. In vivo theranostics at the peri-infarct region in cerebral ischemia

    Theranostics, Vol. 4, Núm. 1, pp. 90-105

  3. Quick adjustment of imaging tracer payload, for in vivo applications of theranostic nanostructures in the brain

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 10, Núm. 4, pp. 851-858

2013

  1. Interleukin-10 facilitates the selection of patients for systemic thrombolysis

    BMC Neurology, Vol. 13

2012

  1. Neuroprotection afforded by antagonists of endothelin-1 receptors in experimental stroke

    Neuropharmacology, Vol. 63, Núm. 8, pp. 1279-1285

  2. Oxaloacetate: A novel neuroprotective for acute ischemic stroke

    International Journal of Biochemistry and Cell Biology

2011

  1. High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 31, Núm. 6, pp. 1387-1393

  2. Imaging techniques for studying functional recovery following a stroke: II. Complementary techniques

    Revista de Neurologia, Vol. 52, Núm. 7, pp. 417-425

  3. Los niveles de expresión de los receptores toll-like 2 y 4 en neutrófilos se asocian con el pronóstico de los pacientes con ictus isquémico

    Revista de Neurologia, Vol. 52, Núm. 1, pp. 12-19

  4. Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: An experimental study

    Journal of Cerebral Blood Flow and Metabolism, Vol. 31, Núm. 6, pp. 1378-1386

  5. Targeting the ischemic penumbra

    Stroke

  6. Toll-like receptors 2 and 4 in ischemic stroke: Outcome and therapeutic values

    Journal of Cerebral Blood Flow and Metabolism, Vol. 31, Núm. 6, pp. 1424-1431

  7. Toll-like receptors 7 and 8 expression is associated with poor outcome and greater inflammatory response in acute ischemic stroke

    Clinical Immunology, Vol. 139, Núm. 2, pp. 193-198

2009

  1. Inflammatory and neuroimmunomodulatory changes in acute cerebral ischemia

    Cerebrovascular Diseases

  2. Reorganización de la vascularización cerebral tras la isquemia

    Revista de Neurologia, Vol. 49, Núm. 12, pp. 645-654